1. Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer. (3rd July 2019) Authors: Tucker, Matthew D.; Zhu, Jason; Marin, Daniele; Gupta, Rajan T.; Gupta, Santosh; Berry, William R.; Ramalingam, Sundhar; Zhang, Tian; Harrison, Michael; Wu, Yuan; Healy, Patrick; Lisi, Stacey; George, Daniel J.; Armstrong, Andrew J. Journal: Cancer medicine Issue: Volume 8:Number 10(2019:Aug.) Page Start: 4644 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer. Issue 7 (1st April 2021) Authors: Ledet, Elisa M.; Burgess, Earle F.; Sokolova, Alexandra O.; Jaeger, Ellen B.; Hatton, Whitley; Moses, Marcus; Miller, Patrick; Cotogno, Patrick; Layton, Jodi; Barata, Pedro; Lewis, Brian E.; Nakazawa, Mari; Zhu, Jason; Dellinger, Beth; Elrefai, Sara; Nafissi, Nellie N.; Egan, Jan B.; Shore, Neal;... Journal: Prostate Issue: Volume 81:Issue 7(2021) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Informational needs of gastrointestinal oncology patients. (7th November 2014) Authors: Papadakos, Janet; Urowitz, Sara; Olmstead, Craig; Jusko Friedman, Audrey; Zhu, Jason; Catton, Pamela Journal: Health expectations Issue: Volume 18:Number 6(2015) Page Start: 3088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A role for the androgen receptor in the treatment of male breast cancer. (February 2016) Authors: Zhu, Jason; Davis, Carter T.; Silberman, Sandra; Spector, Neil; Zhang, Tian Journal: Critical reviews in oncology/hematology Issue: Volume 98(2016) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. Issue 1 (1st February 2019) Authors: Pabla, Sarabjot; Conroy, Jeffrey M.; Nesline, Mary K.; Glenn, Sean T.; Papanicolau-Sengos, Antonios; Burgher, Blake; Hagen, Jacob; Giamo, Vincent; Andreas, Jonathan; Lenzo, Felicia L.; Yirong, Wang; Dy, Grace K.; Yau, Edwin; Early, Amy; Chen, Hongbin; Bshara, Wiam; Madden, Katherine G.; Shirai, K... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma. Issue 10 (17th October 2022) Authors: Brown, Landon C; Zhu, Jason; Desai, Kunal; Kinsey, Emily; Kao, Chester; Lee, Yong Hee; Pabla, Sarabjot; Labriola, Matthew K; Tran, Jennifer; Dragnev, Konstantin H; Tafe, Laura J; Dayyani, Farshid; Gupta, Rajan T; McCall, Shannon; George, Daniel J; Glenn, Sean T; Nesline, Mary K; George, Saby; Zib... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 10(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. MP53-18 CONTINUED PSA SCREENING IN MEN AGED 60 YEARS AND OLDER WITH VERY LOW SERUM PROSTATE SPECIFIC ANTIGEN IN A LARGE, INTEGRATED HEALTHCARE SYSTEM. (May 2022) Authors: Kearns, James; Donahue, Erin; Bose, Rupali; Zhu, Jason; Grigg, Claud; Burgess, Earle; Gaston, Kris; Riggs, Stephen; Matulay, Justin; Clark, Peter Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e902 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. Issue 1 (24th January 2019) Authors: Conroy, Jeffrey M.; Pabla, Sarabjot; Nesline, Mary K.; Glenn, Sean T.; Papanicolau-Sengos, Antonios; Burgher, Blake; Andreas, Jonathan; Giamo, Vincent; Wang, Yirong; Lenzo, Felicia L.; Bshara, Wiam; Khalil, Maya; Dy, Grace K.; Madden, Katherine G.; Shirai, Keisuke; Dragnev, Konstantin; Tafe, Laur... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care System. Issue 6 (23rd November 2021) Authors: Kearns, James T.; Matulay, Justin T.; Anderson, William E.; Hetherington, Timothy C.; Grigg, Claud M.; Zhu, Jason; Gaston, Kris E.; Riggs, Stephen B.; Burgess, Earle F.; Clark, Peter E. Journal: Urology practice Issue: Volume 8:Issue 6(2021) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types. Issue 3 (2nd March 2021) Authors: Brown, Landon C; Tucker, Matthew D; Sedhom, Ramy; Schwartz, Eric B; Zhu, Jason; Kao, Chester; Labriola, Matthew K; Gupta, Rajan T; Marin, Daniele; Wu, Yuan; Gupta, Santosh; Zhang, Tian; Harrison, Michael R; George, Daniel J; Alva, Ajjai; Antonarakis, Emmanuel S; Armstrong, Andrew J Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗